Sometimes, small mistakes become big problems.
Just ask Ferring Pharmaceuticals.
Several years ago, an employee inadvertently switched dosage labels that were printed on a photocopier, triggering a series of events that undermined a pair of late-stage clinical trials and ultimately scrapped a development deal, according to a lawsuit filed by Elobix, its erstwhile partner.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect